<VariationArchive RecordType="classified" VariationID="11621" VariationName="NM_001256789.3(CACNA1F):c.3598-133_3709-76del" VariationType="Deletion" Accession="VCV000011621" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26660" VariationID="11621">
      <GeneList>
        <Gene Symbol="CACNA1F" FullName="calcium voltage-gated channel subunit alpha1 F" GeneID="778" HGNC_ID="HGNC:1393" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49205063" stop="49233340" display_start="49205063" display_stop="49233340" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="49061522" stop="49089832" display_start="49061522" display_stop="49089832" Strand="-" />
          </Location>
          <OMIM>300110</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001256789.3(CACNA1F):c.3598-133_3709-76del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49213978" stop="49214402" display_start="49213978" display_stop="49214402" variantLength="425" positionVCF="49213977" referenceAlleleVCF="GGGCGCCGGAGGGGGGCAGGGCTTCGCTTGGATCACACGATGGGCCTGCACCTGAGTCCCTCTCACTCCCTAGACTCACACTCCCTGGCTGCTGCCCGCATCGCCAACCCCAGAGCTCTGCAATGAGCTCCACTCCCAAGGAATTCATCCACTGGTGGGTGGGGCTAGAGAAGGGGGGCCACCTTGGGCTTGAAGGCGATGATTTTGAGCACCATCTCAATAGTGAAGAGGCCAGTGAAGACCATGTTGAGGATGTCCATGGCATAGTTGAAGGGAGCAGTCTGCTCATAGTGCTGCAGGAGAAAATCAGGTTGAGATGGAGCCTGAGGCAGAGATGCCGCCACACCCAACCAAATATTCCCTGGCCTGGGCTGAGACGAGTCTGGGGACTTGATTGCACTGTGTATTGGTCAAACCTCTTGCACT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="49070438" stop="49070862" display_start="49070438" display_stop="49070862" variantLength="425" positionVCF="49070437" referenceAlleleVCF="GGGCGCCGGAGGGGGGCAGGGCTTCGCTTGGATCACACGATGGGCCTGCACCTGAGTCCCTCTCACTCCCTAGACTCACACTCCCTGGCTGCTGCCCGCATCGCCAACCCCAGAGCTCTGCAATGAGCTCCACTCCCAAGGAATTCATCCACTGGTGGGTGGGGCTAGAGAAGGGGGGCCACCTTGGGCTTGAAGGCGATGATTTTGAGCACCATCTCAATAGTGAAGAGGCCAGTGAAGACCATGTTGAGGATGTCCATGGCATAGTTGAAGGGAGCAGTCTGCTCATAGTGCTGCAGGAGAAAATCAGGTTGAGATGGAGCCTGAGGCAGAGATGCCGCCACACCCAACCAAATATTCCCTGGCCTGGGCTGAGGCGAGTCTGGGGACTTGATTGCACTGTGTATTGGTCAAACCTCTTGCACT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.49070439_49070863del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.49070439_49070863del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.49213979_49214403del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.49213979_49214403del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009095.2" sequenceAccession="NG_009095" sequenceVersion="2" change="g.23965_24389del">
            <Expression>NG_009095.2:g.23965_24389del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256789.3" sequenceAccession="NM_001256789" sequenceVersion="3" change="c.3598-133_3709-76del" MANESelect="true">
            <Expression>NM_001256789.3:c.3598-133_3709-76del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005183.4" sequenceAccession="NM_005183" sequenceVersion="4" change="c.3631-133_3742-76del">
            <Expression>NM_005183.4:c.3631-133_3742-76del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256790.3" sequenceAccession="NM_001256790" sequenceVersion="3" change="c.3436-133_3547-76del">
            <Expression>NM_001256790.3:c.3436-133_3547-76del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300110.0008" DB="OMIM" />
        <XRef Type="rs" ID="2147900556" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001256789.3(CACNA1F):c.3598-133_3709-76del AND Ocular albinism, type II" Accession="RCV000012387" Version="22">
        <ClassifiedConditionList TraitSetID="3171">
          <ClassifiedCondition DB="MedGen" ID="C0268505">Ocular albinism, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2007-06-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14230113</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17525176</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3171" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="47" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ocular albinism, type II</ElementValue>
                <XRef ID="Ocular+albinism%2C+type+II/9031" DB="Genetic Alliance" />
                <XRef ID="266455006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aland island eye disease</ElementValue>
                <XRef ID="MONDO:0010371" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Forsius Eriksson type ocular albinism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AIED</ElementValue>
                <XRef Type="MIM" ID="300600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10574" />
                <XRef ID="10574" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="178333" DB="Orphanet" />
              <XRef ID="C0268505" DB="MedGen" />
              <XRef ID="MONDO:0010371" DB="MONDO" />
              <XRef Type="MIM" ID="300600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32621" SubmissionDate="2010-11-16" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300110.0008_ALAND ISLAND EYE DISEASE" title="CACNA1F, 425-BP DEL_ALAND ISLAND EYE DISEASE" />
        <ClinVarAccession Accession="SCV000032621" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of the original family with Aland Island eye disease (300600) described by Forsius and Eriksson (1964), Jalkanen et al. (2007) identified homozygosity for a 425-bp deletion mutation encompassing exon 30 and portions of adjacent introns of the CACN1F gene. The mutation was found in heterozygous state in carrier females of this family and was not found in samples from 121 Finnish male control subjects. The mutation is predicted to cause a deletion of the transmembrane domain IVS2 and the preceding extracellular loop and consequently an altered membrane topology for the C-terminal part of the protein.</Attribute>
              <Citation>
                <ID Source="PubMed">14230113</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">17525176</ID>
              </Citation>
              <XRef DB="OMIM" ID="300600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1F" />
          </GeneList>
          <Name>CACNA1F, 425-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">425-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300110.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALAND ISLAND EYE DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32621" TraitType="Disease" MappingType="Name" MappingValue="ALAND ISLAND EYE DISEASE" MappingRef="Preferred">
        <MedGen CUI="C0268505" Name="Ocular albinism, type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

